Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-19T06:49:51.174Z Has data issue: false hasContentIssue false

Fifty Cases of Epilepsy Treated with “Tridione.”

Published online by Cambridge University Press:  08 February 2018

J. Hoenig*
Affiliation:
Bethlem Royal Hospital and the Maudsley Hospital, London
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Tridione is established as by far the most powerful drug in the control of petit mal. Many of its clinical aspects, therapeutic as well as toxic, are as yet not clear. In spite of this there is a remarkable absence of reports on the use of it in controlled clinical experiments.

Information

Type
Part I.—Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1951 
Submit a response

eLetters

No eLetters have been published for this article.